Cargando…
Epstein-Barr Virus Binding to CD21 Activates the Initial Viral Promoter via NF-κB Induction
Epstein-Barr virus (EBV), an oncogenic human herpesvirus, binds to and infects normal human B lymphocytes via CD21, the CR2 complement receptor. Studies of the mechanisms that enable EBV to infect nonactivated, noncycling B cells provide compelling evidence for a sequence of events in which EBV bind...
Autores principales: | Sugano, Naoyuki, Chen, Weiping, Roberts, M. Luisa, Cooper, Neil R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2199015/ https://www.ncbi.nlm.nih.gov/pubmed/9271588 |
Ejemplares similares
-
Epstein–Barr virus envelope glycoprotein 110 inhibits NF-κB activation by interacting with NF-κB subunit p65
por: Cai, Mingsheng, et al.
Publicado: (2023) -
Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus
Publicado: (1993) -
NF-κB and IRF7 Pathway Activation by Epstein-Barr Virus Latent Membrane Protein 1
por: Ersing, Ina, et al.
Publicado: (2013) -
Human NF-κB1 Haploinsufficiency and Epstein–Barr Virus-Induced Disease—Molecular Mechanisms and Consequences
por: Hoeger, Birgit, et al.
Publicado: (2018) -
Individualized induction chemotherapy by pre-treatment plasma Epstein-Barr viral DNA in advanced nasopharyngeal carcinoma
por: Zhang, Jian, et al.
Publicado: (2018)